Principal Analyst, Oncology
+13 year(s) experience
Jonathan’s area of expertise is pharmacology, as well as rare diseases. He played a major part in the development of mechanism hierarchy in Pharmaprojects, and has been distinguished for his work in supporting clients.
He joined Informa in 2007 after completing his MPhil in vascular pharmacology from the University of Portsmouth, from which he also has a BSc in pharmacology. Since then, he has held various roles in the editorial team.
Since its inception in the mid-20th century, chemotherapy has been the mainstay of cancer treatment and has become increasingly specific and effective.
Whither the pharmaceutical blockbuster? The pharma industry entered the 21st century buoyed by a series of mega hits that had carried it through the nineties on a wave of promise.